Track the HLB share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, HLB has recorded 30 insider filings. Market capitalisation: €304bn. The latest transaction was disclosed on 16 July 2026 (Other). Among the most active insiders: 진양곤. The full history is free.
29
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,274 of 29,057 companies
17.3
score / 100
Value
19
Quality
16
FCF yld-6.7%
Earn yld-7.2%
EV/EBITDA·
ROE-14%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.